knowledge -WSS

knowledge

author：comprehensive 2025-09-30 18:54:03 - browse：224

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： CVS, Rite Aid closures threaten to worsen pharmacy deserts

explore

WSS

Cancer diagnosis changes perspective doctor, former hospital CEO

J&J lung cancer data amount to new salvo against AstraZeneca

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

A letter from the executive editor: STAT UnitedHealth investigation

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Publishing genetic code of viruses could cause disaster

entertainment

knowledge

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Zepbound, Valneva's vaccine, and more

What does generative AI mean for health care? We asked experts

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Trump demands the U.S. pay no more for drugs than other countries … again

Is there really a nursing shortage in the U.S.?

Peter Hotez and the public health issue of online harassment

Type 2 diabetes prevention programs work at large scale: study

Medicare details structure of new drug price negotiation program

What health policies could hitch a ride on a spending bill?

hotspot

First transplant of an entire human eye performed

What is STAT's opinion section for?

FDA clears Verve to begin U.S. study of gene

ADCs take center stage as promising cancer treatments

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Roche acquires Telavant from Roivant, adding experimental IBD treatment

knowledge

explore

hotspot

hotspot